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Summ2ry 
Large granular lymphocyte (LGL) 1 is a cell surface glycoprotein expressed on a subset (50%) 
of C57BL/6 natural killer (NK) cells. Immunoprecipitation  experiments reveal that the LGL-1 
protein exists as a disulfide-linked  40-kD homodimer. Functional studies of LGL-1 + cells indicate 
that selected H-2  d target cells are not lysed efficiently by these interleukin  (IL)-2-cultured NK 
cells.  These findings suggested that  LGL-1 may be a member of the Ly-49 gene family. Here 
we report  the  molecular  cloning  of the  LGL-1  cDNA  from  a  severe  combined  immunode- 
ficient-adherent lymphokine-activated killer cell library transfected into Cos-7 cells and find LGL-1 
to be homologous to the Ly-49 gene at both the nucleotide (85%) and amino acid levels (73%). 
Sequencing of our LGL-1 cDNA has revealed  it to be nearly identical to the Ly-49G2 cDNA 
recently isolated by cross-hybridization with an Ly-49 probe. LGL-1 represents a type II trans- 
membrane protein of 267 amino acids with its carboxyl end exposed extracellularly. The LGL-1 
protein contains 11 highly conserved cysteine residues and a 25-amino acid transmembrane region. 
Southern blot analysis  demonstrates  that  there are a number  of homologous genes in mouse 
DNA that hybridize strongly to LGL-1. Northern analyses using poly A + RNA from LGL-1 + 
NK cells indicate that LGL-1 is expressed as a 1.4 kb mRNA. Two-color flow cytometry analysis 
(FCA) of C57BL/6 splenic NK cells demonstrates that LGL-1 and Ly-49 label overlapping subsets 
of cells. FCA identifies four subsets of NK cells as defined by LGL-1 versus Ly-49 staining.  We 
have sorted these individual subsets, expanded them in IL-2, and performed cytotoxicity experiments 
to determine their target cell profiles in relation to class I expression.  Results of these studies 
are complex, but indicate that  Ly-49 may not be the only molecule that  recognizes class  I as 
an inhibitory signal for cytotoxicity. LGL-1 + cells also fail to lyse several H-2d-expressing tumor 
targets and concanavalin A lymphoblasts from BALB/c but not C57BL/6 mice. This inhibition 
of lysis by LGL-1 + NK cells is negated by addition of monoclonal antibody (mAb) 4Dll  that 
recognizes the LGL-1 protein.  When mAbs to the class I molecules H-2D a and H-2L  a (oltot~ 
domains only) are added to cytotoxicity assays, LGL-1 + cells lyse H-2 d targets very effectively. 
Therefore, LGL-1 recognizes regions of the class I-specific molecules H-2D a and H-2L  a. This 
specificity distinguishes LGL-1 from Ly-49, whose killing  was only reversed by antibodies to 
H-2D  d. The differential specificities  recognized by LGL-1 versus Ly-49 support the hypothesis 
that this family of genes recognizes diverse class I molecules and regulates the lytic activity of 
NK cells. 
The contents of this publication do not necessarily reflect the views or 
policies of the Department of Health and Human Services,  nor does  mention 
of trade names, commercial products, or organizations imply  endorsement 
by the U.S. Government. 
Animal care was provided in accordance with the procedures outlined 
in the "Guide for the Care and Use of Laboratory Animals" (NIH 
Publication No. 86-23, 1985). 
N 
'K cells have been defined for more than 20 years as a 
population of non-T cell, non-B cell, LGL capable of 
lysing a wide array of vitally infected and tumor target cells 
in a non-MHC-restricted manner.  Evidence that suggests class 
I MHC may indeed affect the ability of NK cells to lyse target 
cells has been accumulating.  However, selected MHC class 
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action of these cells. Data exists both for (1-9) and against 
(10-13) the ability of class I MHC molecules on target cells 
to effect recognition and lysis by NK cells. A number of re- 
cent studies using transfection of specific class I genes into 
target cells presents strong evidence suggesting their role as 
negative regulators of NK lysis (3, 5-7). Both in the human 
and murine systems, NK cells have been shown to be incapable 
of lysing target cells expressing high levels of class I mole- 
cules. In the murine system, Ly-49 has been shown to inhibit 
NK  reactivity against  target  cells  expressing  H-2D  d and 
H-2D  k, and this specificity appears to reside at the olta2 do- 
main of H-2D  d (4).  Ly-49 is  expressed on a  small  subset 
(20%) of NK cells in B6 mice, but is polymorphic in its dis- 
tribution on other strains of mice. Cloning and sequencing 
of the Ly-49 gene places it in the C-type lectin family of type 
II transmembrane proteins (14) that maps to chromosome 
6 (15) along with other members of the NK complex (16). 
This laboratory has previously generated and characterized 
an mAb (4Dll) that recognizes a nonallelic determinant, re- 
ferred to as LGL-1, that is present on 50% of murine NK 
cells in B6 mice (17). We also have demonstrated that LGL- 
1 + cells,  upon IL-2 activation and culture, are not capable 
of lysing selected tumor cell targets expressing high levels 
of H-2  a such as P815 and L5178Y (18). LGL-1 has been bio- 
chemically characterized as a 40-kD disulfide-linked homo- 
dimer. Therefore, the functional and biochemical character- 
istics of the LGL-1 molecule are quite similar to those of the 
Ly-49 molecule. In this report, we present data on the cloning 
and sequencing of the LGL-1 cDNA along with the func- 
tional properties of NK cells expressing LGL-1 and Ly-49. 
Sequencing data have revealed that LGL-1 is a member of 
the Ly-49 gene family and has a high degree of homology 
at both the nucleotide (85%) and amino acid (73%) levels. 
We also have performed cell sorting of NK cells expressing 
LGL-1 versus Ly-49, and we have analyzed the functional prop- 
erties of the four resulting subsets after culturing these cells 
in IL-2. Analysis of both tumor targets and Con A  blasts 
indicate that both LGL-1 + and Ly-49 + NK cells are not able 
to lyse  target cells  expressing high levels of H-2  a.  Ly-49 § 
NK cells appear to be inhibited even when target cells ex- 
press low levels of class I on their surfaces.  The presence of 
multiple Ly-49-related gene products on NK cell subsets im- 
plies a complicated mechanism of NK lytic function regulation. 
Materials  and Methods 
Cloning of LGL-I.  Poly A § RNA obtained from CB.17 severe 
combined immunodeficiency-adherent  lymphokine-activated  killing 
(SCID-ALAK)  1  NK cells was used to prepare a cDNA library and 
were inserted into the pME18S plasmid expression  vector (Stoneman, 
1 Abbreviations used in  this paper: FBS, fetal bovine serum; FCA, flow 
cytometry  analysis; LB, Luria-Bertani  broth; RADCC, reverse  antibody- 
dependent cellular cytoxicity;  SCID-ALAK, severe combined immuno- 
deficiency-adherent  lymphokine-activated  killing. 
E., P. A. Mathews, V. Kumar, and M. Bennett,  manuscript sub- 
mitted for publication). Cos-7 cells were transfected using a mod- 
ification of the Seed-Amffo  method (19). Cells were grown to 70% 
confluency in DMEM, washed, and 10 #g of plasmid DNA was 
added in a 1:50 dilution of  Lipofectamine (GIBCO BRL, Gaithers- 
burg, MD). After 5 h at 37~  the cells  were washed  once in DMEM 
and trypsinized to remove adherent cells. After washing once in 
DMEM +  10% fetal bovine serum (FBS), the cells were replated 
and grown for 48-72 h at 37~  Cells were detached and collected 
with HBSS (Ca  2+ and Mg  2§  free) +  0.5 mM EDTA +  0.02% 
azide after incubation for 30 min at 37~  Cells were washed and 
stained with a 1:500 dilution of mAb 4Dll and incubated on ice 
for 1 h. Panning was performed for 2-3 h at room temperature 
using  an  F(ab')2 goat  anti-rat  Fc-specific antibody  (10 #g/ml; 
Jackson Laboratories, Bar Harbor,  ME) attached to petri plates 
(Falcon 1007). Nonadherent cells were gently removed by washing 
three times with HBSS  +  EDTA  +  0.02% azide  +  5% FBS. 
Adherent 4Dll § Cos-7 cells were disrupted with 0.4 ml of a 0.6% 
SDS solution containing 10 mM EDTA for 5-10 min at room tem- 
perature. The solution was adjusted to 1 M NaC1 and placed on 
ice overnight. After centrifugation,  plasmid DNA was extracted 
from the supernate with phenol/phenol-chloroform/chloroform, 
precipitated, and resuspended in 20 #1 Tris-EDTA  buffer and used 
to transform DH5c~ cells (GIBCO BRL, Gaithersburg, MD). Bac- 
terial cells were grown in Luria-Bertani broth (LB) +  50 #g/ml 
ampicillin overnight,  and plasmid DNA was extracted and used 
for successive  rounds of Cos-7 transfection and panning. After the 
third round of transfection, the bulk population of Cos-7 cells was 
stained with 4Dll and FITC goat anti-rat y2a and examined by 
flow cytometry analysis (FCA) for 4Dll + cells. After the fourth 
round of transfection (resulting in •10%  4Dll § cells), plasmid 
isolation, and DH5a transformation,  50 colonies were isolated. 
Miniplasmid preps were made from each and pooled into five  groups 
of 10,  transfected into Cos-7 cells, and 4Dll § cells were deter- 
mined by FCA.  In this manner, a single LGL-1  + clone was iso- 
lated that, upon transfection and expression in Cos-7 cells, resulted 
in '~40% 4Dll § cells. 
DNA  Sequencing.  Plasmid  cDNA containing the LGL-1 insert 
was cleaved with EcoRI and Not1, digested with HaelII, AluI, 
or  Sau3A, and  cloned  into  the  appropriate  restriction  site of 
M13mp18. Single-stranded template DNA was purified and se- 
quenced with Sequenase (United States Biochemical Corp., Cleve- 
land, OH). Both strands of all possible fragments were sequenced 
as previously described (20). 
Southern Blotting.  DNA for Southern blotting was prepared  from 
mouse and rat spleens and digested with HindlII, PvulI, SstI, or 
EcogI. Electrophoresis and blotting were performed as described 
previously (20). Hybridization was performed with the 1.0-kb in- 
sert from the EcoRI-NotI-digested LGbl plasmid DNA.  The 
LGL-1 probe  was  synthesized  by  the  random-primed  method 
(GIBCO BRL) using  [ot-32p]dATP  as the label. Low stringency 
conditions consisted of hybridization at 42~  in formamide fol- 
lowed by washes at 50~  in 0.2  x  SSC  +  0.1% SDS. Higher 
stringency conditions included washes at 65~  in the same wash 
buffer. 
Northern  Blotting.  LGL-1  + and LGL-1- subsets were isolated 
from splenic B6 NK cells by cell sorting  and were expanded in 
culture with IL-2.  Poly A § RNA was extracted (Microprep; Phar- 
macia Fine Chemicals, Piscataway, NJ), electrophoresed on a 1% 
agarose/formaldehyde gel,  and blotted onto a nylon membrane 
(Amersham Corp.,  Arlington Heights,  IL) in 10  x  SSC. Blots 
were hybridized using  an  o~-32p-labeled LGL-1 probe at  106-107 
cpm/ml in 5  x  SSC  +  0.1% SDS at 65~  for 24-72 h, washed 
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film for 24-72 h. 
Immunoprecipitation and SDS-PAGE.  Cos-7 and NK cells were 
radiolabeled with  t~I using the lactoperoxidase method and im- 
munoprecipitated as previously described (21). Briefly, 5-10  x  106 
cells were radiolabeled, lysed in 0.5%  Triton X-100,  and solubi- 
lized membranes immunoprecipitated with mAb 4Dll or a con- 
trol rat IgG2a cross-linked to protein G-Sepharose (Pharmacia,  Upp- 
sala, Sweden). After extensive washing,  immune complexes were 
eluted in reducing and nonreducing  buffers and electrophoresed 
on a 10% SDS-PAGE.  Gels were dried and exposed to film for var- 
ious times. 
Antibodies.  All mAbs used were derived from 2x  salt-cut as- 
cite preparations. Rat IgG2a mAbs included 4Dll  (LGL-1) and a 
control R3'2A. Mouse IgG2a mAbs included PK136 (NK-I.1), A1 
(Ly-49),  and (Ly-2.2).  Marl8.5  (goat anti-mouse K) was used as 
a facilitating antibody along with MT4 to eliminate CD4 § cells 
during NK enrichment./nAb  2.4G2 is a rat IgG that specifically 
reacts with the Fc3~RII/III on the surface of murine NK cells and 
was used to stain target cells. The following antibodies were ob- 
tained from PharMingen  (San Diego, CA) to either stain tumor 
targets for class I expression by FCA or as blocking antibodies in 
cytotoxicity assays: ot-H2-K  b (clone AF6-8815),  ot-H2-K  d (clone 
SFI-I.1), c~-H2-D  b (clone KH95), ~-H2-D  a (clone 34.2.12),  and 
c~-H2-D  ~ (clone  15.5.5).  Antibodies  to  specific  domains  were 
kindly provided by Dr. David Margulies (National Institute of Al- 
lergies and Infectious Diseases, Bethesda, MD) and included ot-H2- 
D%eloe2 (clone 34.5.8S),  c~-H2-Ldc~tc~2  (clone 30.5.7S),  c~-H2-Ddc~3 
(34.2.12),  and c~-H2-Ldcr3 (28.14.8S)  (22,  23,  23a). 
Target Cells and Cytotoxicity Assays.  All tumor cell targets were 
propagated in RPMI  +  5% FBS as previously described (18). Con 
A  lymphoblasts  were  prepared  from  splenocytes  of C57BL/6, 
BALB/c, or B6  x  BALB/cF1 as described by Chadwick and Miller 
(24).  Essentially,  single-ceU  suspensions  were  prepared  at  106 
cells/ml in RPMI  +  10%  FBS, including 3/zg/ml of Con A  in 
T-25 flasks.  Cells were incubated for 40-48 h  at 37~  Lympho- 
blasts were isolated from nonviable cells by separation on Lympho- 
lyte-M (Accurate Chemical and Science  Corp.,  Westbury,  NY). 
Cells were washed once in RPMI and prepared for radiolabeling 
with  51Cr. SlCr  release  assays were performed as previously de- 
scribed (21). Cytotoxicity assays using mAb involved the inclusion 
of the antibodies for the duration of the 4-h assay at a final concen- 
tration of 2/~g per well. All class I antibodies used in cytotoxicity 
assays were  added  directly  to  the  assay  at  a  concentration  of 1 
/zg/well.  Spontaneous  release of Con A blasts was <25% and tumor 
targets <20%  in  all assays. 
FCA.  FCA was performed on a FACScan  |  (Becton Dickinson 
&  Co.,  Mountain  View,  CA).  NK cells  were stained essentially 
as previously described (21). mAb 4Dll was directly labeled either 
with PE or FITC. mAb A1 was used as a 2x  salt-cut preparation 
at a 1:1,000 dilution followed by a FITC c~MouselgG2a (CALTAG 
Laboratories, Inc., South  San  Francisco,  CA). 
NK Cell Isolation and Cell Sorting.  NK cells from B6 mice were 
enriched from spleens of 12-16-wk-old animals by collecting nylon 
wool nonadherent cells, depletion of T cells using mAbs to Ly-2.2 
and CD4, and removal of B cells by immunoabsorbance to plates 
as described previously (18).  Routinely,  75-80%  of the resulting 
cells  were  NKI.1 +  .  Cells were  stained  as described  above with 
mAb A1 followed by a combination of FITC ~MouselgG2a plus 
4Dll PE. Cells were sorted on either a FACStar |  (Becton Dick- 
inson & Co.) or an Epics 753  (Coulter Electronics,  Hialeah, FL) 
ceU sorter.  NK cell subsets were isolated and cultured in high dose 
IL-2 (103 U/ml)  for 6-8 d  as described previously (18). 
Results 
Cloning ofLGL-1 cDNA.  A modification of the Seed and 
Aruffo (19) method for transfection,  enrichment,  and isola- 
tion of cDNAs that encode cell surface proteins has been used 
to clone LGL-1 cDNA.  An NK-cDNA library derived from 
CB.17  SCID-ALAK  cells  that  had  been  cloned  into  the 
pME18S expression vector was obtained.  Lipofectamine was 
used as the method of transfecting Cos-7 cells to obtain max- 
imal efficiency, followed by panning LGbl §  cells with mAb 
4Dll and transformation of DH5oe cells with enriched plasmid 
preparations.  Plasmid cDNA from the fourth round  of en- 
richment was used to transform DH5ot cells that were plated 
onto LB  +  ampicillin plates.  50 colonies were selected,  and 
plasmid preparations were pooled, transfected into Cos-7 cells, 
and examined for LGL-1 expression by FCA.  A  single clone 
(No.  16) containing the LGbl cDNA was isolated (data not 
shown). 
Immunoprecipitation  of  LGL-I  from  Transfected  Cos-7 
Cells.  To confirm that clone No.  16 contained  cDNA en- 
coding the LGbl protein, immunoprecipitation of Cos-7 cells 
transfected with clone No. 16 plasmid cDNA was performed. 
Fig. 1, A  and B, demonstrates the results of immunoprecipi- 
tation followed by SDS-PAGE under both nonreducing (Fig. 
1 A)  and reducing  conditions  (Fig.  1 B).  Fig.  1 A  demon- 
strates  that  plasmid cDNA  from clone  No.  16  encodes  an 
~87-kD  protein  under  nonreducing  conditions  and  a 
homodimer  of ,,o40 kD  under  reducing  conditions  (Fig.  1 
Figure  1.  Immunoprecipitation of 
Cos-7 cells transfected  with the cloned 
LGL-1 plasmid. (.4) Cos-7 cells were 
either  transfected  with  a  control 
plasmid DNA preparation  (lanes  3 and 
4) or plasmid  DNA from LGL-1  (lanes 
5 and 6). IL-2-cultured NK cells were 
included for comparison in lanes I 
and 2. All cells were labeled  with 125I 
and immunoprecipitation performed 
with either an isotope control mAb 
(R3'2A) (lanes I, 3, and 5) or mAb 
4Dll  (lanes  2,  4,  and  6).  10% 
SDS-polyacrylamide gels were elec- 
trophoresed under nonreducing con- 
ditions.  (B)  Identical  10%  SDS- 
polyacrylamide gels electrophoresed 
under reducing conditions. 
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protein. Lanes 1 (control) and 2 (4Dll) represent immuno- 
precipitates  from IL-2-cultured B6 NK cells; lanes 3  (con- 
trol) and 4 (4Dll) represent negative control-transfected cell 
lysates; and lanes 5 (control) and 6 (4Dll) represent cells trans- 
fected with plasmid cDNA from clone No.  16.  It appears 
from these gels that transfection of Cos-7 cells with LGL-1 
cDNA generates a protein that is of a slightly higher molec- 
ular weight than that seen in NK cells. Both the nonreduced 
87-kD and reduced 40-kD bands migrate somewhat slower 
when immunoprecipitated  from transfected Cos-7 cells than 
from NK cells, probably because of differences in glycosyla- 
tion of the LGL-1 protein in Cos-7 cells. However, the mo- 
lecular weight of the proteins immunoprecipitated  with 4Dll 
from transfected Cos-7 cells was consistent with that obtained 
from NK cells, demonstrating that clone No. 16 encodes the 
LGL-1 protein. 
Sequencing  of  LGL-I eDNA.  Plasmid encoding the LGL-1 
protein was digested with EcoRI and Not1, and was found 
to contain a 1.0-kb cDNA fragment. Sequencing of this frag- 
ment revealed 1,042 bp encoding a protein of 267 amino acids 
(Fig. 2 A). An untranslated 30-bp segment resides at the 5' 
region and a 210-bp segment at the 3' region of the LGL-1 
cDNA. Comparison of LGL-1 to the reported Ly-49 cDNA 
sequence reveals a high degree of homology at both the nucleo- 
tide and amino acid levels. Fig.  2 B demonstrates a best-fit 
alignment of the three most recently characterized  members 
of the Ly-49 gene family. In this figure, the amino acid se- 
quence of LGL-1 is compared with that of Ly-49 and SW5E6, 
a recently cloned molecule (24a) defining a subset of NK cells 
that may play a role in regulating hematopoiesis (Yu, Y. Y., 
J. Roland, V. Kumar, and M. Bennett, manuscript submitted 
for publication). SWSE6 also has been determined to be an 
Ly-49 family member with ~65%  homology to Ly-49 at 
the protein level. The biological role of 5E6 + NK cells per- 
taining to class I inhibition is currently under investigation. 
LGL-1 and Ly-49 display an overall homology of 85% at the 
nucleotide level with a corresponding 73% amino acid ho- 
mology. The amino acid composition of this type II trans- 
membrane protein indicates that it belongs in the Ly-49 gene 
family of proteins. A  presumed intracellular domain of 44 
amino acids is found at the NHz terminus of the LGL-1 pro- 
tein that contains possible phosphorylation sites for casein 
kinase, protein kinase C, cAMP-dependent protein kinase, 
and tyrosine kinases.  This is followed by a 25-amino acid 
transmembrane region. The extraceUular  domain of the LGL-1 
protein contains 10 cysteine molecules that are highly con- 
served in the Ly-49 gene family. These highly conserved cys- 
teine molecules would  appear  to  account  for  the  strong 
disulfide-linked  nature  of LGL-1,  Ly-49,  and  the SW5E6 
homodimers. The LGL-1 cDNA also contains three N-linked 
glycosylation motifs that account for the glycosylated nature 
of the LGL-1 protein (21). A unique feature of the LGL-1 
protein is a four-amino acid segment (RPGN)  that is not 
A 
MSEQEVTYST  (10) 
~TCCTCGACCCACGCGTCCGCCC~GATGAGTGAGCA~AGGTCACTTACTC~CTG  60 
g  gaa a  actt  atacatcatt 
VRFHESSRLQKLVRTEEPQR  (30) 
TGAGATTTCATGAGTCTTC~GGTTGCAGAAACTAGTGAGGACTGAGGAGCCTCAAAGGC  120 
PREACYRKYSVPWKLIyIA~  (50) 
CCAGAG~TTGCTACAGAAAGTATTCAGTCCCCTGG~GCTCAT~TGATAGCTTGTG  180 
g 
GIF~LLLVTVALLAITIFQ  (70) 
G~TCT~TGT~CC~CTCCTGGT~CTGTT~ATTG~G~T~CGAT~TTCAGC  240 
c 
S~QQKHESQETLNCHD~--~--~T  (901 
ATATTC~CAAAAACATG~CTACA~AAACTCTAAACTGCCACGAT~CTGCAGCACCA  300 
g  t  C 
TQSDVNLKDELLR~--~---~IECR  (if0) 
C~AAAGTGACGTC~C~G~GGATG~CTGC~AGAAAT~GTCTATAGAGTGTAGGC  360 
PGNDLLESLNRDQKRWYSET  (130) 
CA~C~ATCTTCTGG~TCCCTC~CAGGGATCAGAAAAGATGGTACAGTGAAACTA  420 
g  c  C 
KTFSDSSQHTGRGFEKYWFC  (150) 
AGACT~TTCAGATTCCTCACAC, CACACAGGTAGAGGTTTTGAAAAATATTGGTTCTGTT  480 
YGIKCYYPDMDRKTWSGCKQ  (170) 
ATGGTATAAAA~TTATTATT~GACAT~ACAGAAAAACAT~TGGATGTAAACAGA  540 
a  g 
TCQISSLSLLKIDNEDELKF  (190) 
CCTGCCAGATTTCCAGCTTATCCCTTCTG~GATAGAC~TGAGGATG~CTG~GTTCC  600 
LQNLAPSDISWIGFSYDNKK  (210) 
T~AG~CCTGGCTCCTTCAGACAT~CCTGGATT~A~TTCATATGAC~T~GAAAA  660 
g 
KDWAWIDNGPSK~AL~---~Ky  (230) 
~GATTGG~ATGGATTG~TGGCCCATCGAAACTT~C~G~CAC~CAAAATATA  720 
t  t  g 
NIRDGLCMSLSKTRLDNGDC  (250) 
ATATAAGAGAT~ATTATGTATGTCGTTATCTAAAAC~GACTAGAC~T~GGACTGTG  780 
GKSYICICGKRLDKFPY*  (267) 
GTAAATCATACATCTGTAT~GTG~GAGACT~ATAAATTCCCTTA~GACTCTCCA  840 
a  tc 
ATGAGTGTAAAAGTGTAAAGAGAGAGAC~TCTGG~GA~TTG~TGTTCTCTGAAA  900 
C 
~TGACATGACAGA~AGAGG~ATCTTCCTTCCTTG~GAGACTGGACAGATCTACTCT  960 
a  c 
GGTTCCCCAAA~TT~ATG~TCTGATTTAT~GTTTCCATAAACTCCAGTAAAAGT~  1020 
c  ******  g  a 
ATAAAG~CCTT~T~CTAGpA  1041 
1030  1040 
Figure  2.  Nucleotide sequence and proposed  amino acid sequence of 
LGL-1 compared  with Ly-49 and 5E6. (A) The complete  nucleotide  se- 
quence of the 1.0-kb fragment of cDNA encoding the LGL-1 molecule 
is presented.  The nucleotide  number is shown to the right of each line, 
and the amino acid number is shown in parentheses. 30 bp at the 5' and 
210 bp at the 3' end of the molecule are untranslated.  Differences in nuc- 
leotide sequence between LGL-1 and Ly-49G2 are notated as lower case 
letters directly beneath the LGL-1 sequence. The 801-bp coding region trans- 
lates into a 267-amino acid protein as noted above the nucleotide sequence. 
The proposed transmembrane  region is underlined  and the three potential 
N-linked glycosylation  sites are boxed.  (B) Alignment of the proposed 
amino acids of LGbl compared with Ly-49 and SW5E6. The transmem- 
brahe region of the protein  is underlined.  Shaded areas represent areas of 
homology as opposed  to unshaded  areas, which represent  differences in 
amino acid content. Homologous cysteines are boxed, and dots represent 
deletions  of specific amino acids. 
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of LGL-1 indicates that it belongs in the family of type II 
integral membrane proteins, along with Ly-49, with which 
it  shares  the highest degree of homology. 
Northern  Blot Analysis.  To determine if LGL-1 mRNA 
correlates with NK cells  expressing the LGL-1 protein, as 
well  as  to  determine  the  size  of the  mRNA  transcript, 
Northern blotting was performed. NK cells from B6 mice 
were sorted into LGL-1 + and LGL-1- populations, expanded 
in IL-2, and used to isolate poly A + RNA.  A  1.4-kb mes- 
sage was demonstrated in LGL-1 + cells (Fig.  3, top); how- 
ever, LGL-1- cells did not display any significant hybridiza- 
tion, demonstrating that the LGL-1 message is confined to 
NK cells expressing the LGL-1 protein. A control probe for 
/3-actin  was later applied to the same blot (Fig.  3,  bottom) 
and indicated that there was approximately the same amount 
of mRNA present in each lane.  The observed hybridization 
was  not  caused by crosshybridization between the LGL-1 
cDNA probe and Ly-49 since Ly-49  + cells are found in both 
LGL-1 + and LGL-1- populations at the same levels ("~25%). 
These results  indicate that  although  there appear to be a 
number of Ly-49 gene family members, Northern blot anal- 
ysis under stringent conditions allows for the specific detec- 
tion of individual family members. 
Southern Blot Analysis.  Restriction enzyme digests of rat 
and CB.17 SCID mouse DNA, followed by blotting and hy- 
bridization with our 1.0-kb LGL-1 cDNA probe, reveal  a 
large number of hybridizing bands (Fig. 4 A). In this figure, 
hybridization was performed at 42~  followed by washes 
at 50~  in 0.2  x  SSC plus 0.1% SDS (low stringency con- 
ditions). These results demonstrate that as many as 11 bands 
in the rat and up to 9 bands in the mouse hybridize with 
the LGL-1 cDNA. However, after washing the blot at much 
higher stringency (65~  virtually all of the rat bands and 
several of the mouse bands are no longer present, indicating 
only weak homology of these bands (Fig.  4 B). Data with 
human DNA did not reveal any specific hybridization after 
low or high stringency washes.  Our data using LGL-1 as a 
probe is therefore similar to that found using the 639-bp probe 
of Ly-49 (15).  The overall results of our Southern blotting 
procedures indicate that  while there are a  number of Ly- 
49-related genes in the mouse, there may not be any genes 
with a high degree of homology in the rat or human ge- 
nome. If there are any homologous genes in humans, they 
apparently are much more evolutionarily divergent. 
LGL-1  versus Ly-49 Subset Analysis of NK Cells.  FCA of 
highly enriched populations of B6 splenic NK cells reveals 
four distinct subsets of cells when stained for LGL-1 and Ly- 
49.  Fig.  5 A  demonstrates that 32%  of the cells  are LGL- 
1+Ly-49 -  (quadrant 1),  8%  LGL-l+Ly-49  +  (quadrant 2), 
53% LGL-1-Ly-49- (quadrant 3),  and 7% LGL-1-Ly-49  + 
(quadrant 4). Because the number of NK-I.1 + cells after en- 
richment was  ~o75%,  the LGL-1-Ly-49- population also 
contains these non-NK cells. Previous data from this labora- 
Figure 3.  Northern  blot analysis. Poly A + 
RNA was obtained  from  IL-2-cultured  NK cells, 
electrophoresed, and blotted onto nylon mem- 
branes. (A) The 1.0-kb LGL-1  cDNA fragment 
was labeled  with [ot-32p]dATP  using the random 
priming method and hybridized  at 65~  for 48 
h.  Lane 1  represents RNA  from the  bulk 
presorted population of  NK  cells; lane 2 
represents RNA from the 4Dll + subset; and 
lane 3 represents  ILNA from the 4Dll- subset. 
A 1.4-kb  message  hybridizes  with the presorted 
and 4Dll + RNA only. (B) /3-actin was used 
after  stripping  the blot as a control  for the amount 
of mRNA applied to each lane. 
Figure 4.  Southern  blot analysis. DNA isolated from rat and mouse 
spleen was digested with the following  restriction  enzymes:  lanes I and 
5, HindlII; lanes 2 and 6, PvuI; lanes 3 and 7, Sstl; and lanes 4 and 8, 
EcoRl. Digests were applied to gels, electrophoresed,  and blotted onto 
nylon membranes. Hybridization  with the 1.0-kb LGL-1  fragment after 
labeling with [oe-32p]  dATP was performed  at 42~  Blots were washed 
under either nonstringent (50~  A) or stringent (65~  B) conditions 
to determine  the relative  degree  of homology  between the two species. 
297  Mason  et al. Figure 5.  (A) FCA of  LGL-1  versus  Ly-49  on splenic  B6 NK cens. Freshly 
isolated splenic NK cells were enriched from B6 mice after nylon  wool 
nonadherent cells were depleted of CD4 § and CD8 § cells by antibody 
+ c' followed  by panning to remove  residual  B cells. The resulting  cells 
were >75% NK-I.1  +. NK cells were stained with mAb A1, washed, and 
sandwiched with a FITC-amouse3`2A + mAb 4Dll PE. FITC-labeled 
cells (Ly-49  +) and PE-labeled  cells (LGL-1)  were  analyzed  on a FACScan  | 
and divided  into quadrants  based  on staining  with control  antibodies.  Quad- 
rant 1, LGL-1  § Ly-49- = 32%; quadrant  2, LGL-l+Ly-49  + = 8%; quad- 
rant 3, LGL-1- Ly-49- = 53%; and quadrant  4, LGD1-Ly-49  + = 7%. 
(B) H-2  d expression of tumor target cells. Tumor targets were prepared 
for FCA by staining  cells with anti-H-2D  a (clone 34-2-12) followed  by 
FITC goat anti-mouse  3' 2A. A and B are representative  of at least three 
similar determinations. 
tory has shown that LGL-1 + cells do not lyse selected tumor 
target cells such as P815 and L5178Y, both of which express 
high levels of class I  (H-2D  d) (18). However, examination 
of a panel of tumor targets for a correlation between H-2  d 
expression  and resistance  to lysis by LGL-1 + cells was not 
very strong.  Since Ly-49 + cells do not lyse H-2  a or H-2  k 
targets, the Ly-49 § subset of NK cells (•20%)  within the 
LGL-1 + (*40%) population could represent a major effec- 
tot cell  subset.  Therefore, Ly-49+LGL-1  §  cells  might ex- 
plain  to  a  certain  degree  the  poor  lysis  of H-2d-bearing 
targets by LGL-1 + cells. Our observation that '~25% of the 
total LGL-1 + cells  coexpress  Ly-49 indicated that further 
subset analysis  would be necessary to evaluate the lytic potential 
of these NK cell  subsets. 
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Functional Analysis  of LGL-I + versus Ly-49 + NK  Cells. 
To further examine the functional properties of the LGL-1 
and Ly-49 + subsets, it was necessary to separate the subsets 
expressing either LGL-1 or Ly-49 alone from those expressing 
both phenotypic markers  (LGL-1 +Ly-49+). Splenic NK cells 
from B6 mice were enriched, stained, sorted into the following 
subsets,  and cultured in high-dose IL-2:  total Ly-49 + cells 
(18%), LGL-l+Ly-49  -  (35%),  and LGL-1-Ly-49- (47%). 
Table  1 confirms previously published data that  the total 
Ly-49 + subset of NK cells  does not lyse the majority of 
targets expressing H-2D  d. However, both P338D1  and Raw 
264,  which express low to zero levels of H-2D  d, are lysed 
somewhat more efficiently than the other H-2  d targets. In 
addition, the LGL-1 § subset  of NK cells, upon removal  of 
any Ly-49 + cells (LGL-1 +Ly-49-), did not lyse target cells 
that  express  very high levels  of H-2  a,  such  as  P815 and 
L5178Y. Tumor targets expressing somewhat lower levels of 
H-2  a,  such as WEHI-164  and more notably P388D1  and 
Raw 264 (Fig.  5 B), are lysed much more efficiently by the 
LGL-1 + cells. NK cells lacking expression of LGL-1 and Ly- 
49 appear to be quite capable of lysing all tumor cells exam- 
ined.  Of interest, this LGL-1-Ly-49- subset  actually con- 
rains enhanced levels of cytotoxicity  against these tumor targets 
compared with the presorted population. Therefore, NK cells 
expressing  the LGL-1 phenotype are similar, but not iden- 
tical,  to Ly-49 + cells in their inability to lyse H-2  a tumor 
targets. The inhibition by tumor targets, however,  appears 
to  be  generally  associated  with  high  levels of H-2  d ex- 
pression. 
The lysis of tumor cells, although modulated by the ex- 
pression of class I MHC molecules,  is likely to be influenced 
by other adhesion/triggering molecules as well. We there- 
fore used normal Con A  lymphoblasts (24)  to further ex- 
amine the role of LGL-1 + and Ly-49 + cells in the lysis of 
class I-expressing target cells. The data presented in Fig.  6 
show that NK cells expressing either LGL-1 or Ly-49 are not 
capable  of lysing tumor  targets  expressing high levels of 
H-2  d  (Fig.  6  A)  or  normal  Con  A  lymphoblasts  from 
BALB/c mice that are H-2  d+ (Fig. 6 D). NK cells expressing 
LGL-1 and/or Ly-49 are fully capable of lysing tumor target 
cells expressing H-2  b (Fig.  6 B)  and Con A  lymphoblasts 
from  C57BL/6  mice  that  are  H-2  b+  (Fig.  6  C).  These 
results support the hypothesis that both the LGL-1 and Ly-49 
molecules  transmit  negative signals  for  lysis  of H-2d-ex  - 
pressing targets. 
mAbs 41911 and A1 Overcome  Inhibitory Effects of  Class I.  To 
ascertain whether the LGL-1 and Ly-49 molecules on the sur- 
face of NK cells are directly involved in class I inhibition of 
lysis, antibody-blocking assays have been used.  Using NK 
subsets  expressing  either  the LGL-1 +  or Ly-49 + markers 
alone, or in combination, cytotoxicity  assays  were performed 
in the presence  of various antibodies. We used the tumor 
targets P815 (H-2  d+ and FcyRII  +) and WEHI-164 (H-2  a+ 
but FcyRII-). Both types of targets were used to ensure 
that altered levels of lysis was not caused by a reverse-type 
ADCC (RADCC) mechanism. 
Table 2, A and B, presents the results of the lytic data ob- 
tained when mAb to LGL-1 (4Dll), Ly-49 (A1), and the NK- Table  1.  Lytic Function  of LGL-1 + versus Ly-49 + NK  Cells 
YAC  P815  L5178Y  WEHI-164  P388D1  Raw  264  EL-4  MBL-2 
NK subsets  (a)  (d-4 §  (d-4 +)  (d-3 + )  (d-1 +)  (d-o)  (b)  (b) 
Presorted  2,600  55  41  413  2,860  1,175  394  569 
Ly-49 §  (total)  1,524  1  <1  9  1,641  139  409  315 
LGL-1 §  2,656  4  6  293  2,412  1,371  424  442 
LGL-1 -Ly-49-  5,013  247  250  795  4,816  4,459  476  722 
NK cells were enriched from C57BL/6 spleens and stained for LGL-1 and Ly-49. Cells were sorted into subsets containing  total Ly-49 + cells (18%), 
LGL-1+Ly-49 -  cells (35%),  and LGL-1-Ly-49- cells (47%)  and cultured in high-dose  IL-2 for 7 d.  At day 7,  the subsets were stained  and ex- 
amined  for LGL-1  and Ly-49  expression  as follows: presorted  (LGL-1  =  60%,  Ly-49  =  23%); total Ly-49 + (LGL-1  =  65%, Ly-49  =  97%); 
LGL-l+Ly-49-  (LGL-1  =  98%, Ly-49  =  0); and LGL-1-Ly-49- (LGL-1  =  2%, Ly-49  = 1%). Cells were washed  twice before assaying. Tumor 
target cells were labeled with slCr and cytotoxicity assays performed at E/T ratios  starting at 20:1.  LU at 30% per 107 cells are presented.  Letters 
and numbers in parentheses represent  the H-2 haplotype  of the target  and its relative degree of expression by FCA on a 0-4 + scale. This is a represen- 
tative experiment of at  least three similar  assays performed. 
1.1 (PK136) markers were added to 4-h cytotoxicity assays 
against either P815 or WEHIo164. These results demonstrate 
that  addition of mAb 4Dll,  A1,  or 4Dll  +  A1 enhances 
lysis against both Fc3'RII + P815  and Fc3'RII-  WEHI-164 
targets when the effector cells express either LGL-1, Ly-49, 
or both markers  simultaneously.  The specificity of this re- 
sponse was shown by the increased lysis observed with LGL- 
1+Ly-49- cells upon addition of mAb 4Dll  (anti-LGL-1), 
but not by mAb A1 (anti-Ly-49). A more pronounced effect 
is seen with cells expressing both LGL-1 and Ly-49, where 
addition ofmAb 4Dll  +  A1 produces a synergistic response 
in lysing P815.  Similar  specificity is provided in  the LGL- 
1-Ly-49-  subset,  which does not respond with  enhanced 
lysis to addition of either mAb 4Dll  or A1.  These results 
indicate that  class I inhibition  seen  with LGL-1 + cells can 
be reversed by addition of mAb 4Dll, and they confirm the 
data of Karlhofer et al.  (7) that  mAb A1 can reverse  class 
I  inhibition  mediated by Ly-49 §  NK cells. 
Antibodies  to H2-D'lce lce  2 and H2-L 'tcelcr  2 Reverse Inhibition 
ofLGL-I  + NK  Cells.  To confirm that  inhibition  of cyto- 
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Figure  6.  Lysis of Con  A  lym- 
phoblasts and tumor targets by LGb 
1 + and Ly-49 + NK cell subsets. NK 
cells were enriched from B6 spleens, 
stained  with mAb A1  followed  by 
FITC c~ M3'2A plus 4Dll PE,  and 
sorted into the respective subsets: total 
LGL-1 + (43%);  total LGL-1- (57%); 
LGbl+Ly-49 +  (11%);  and  LGL- 
1-Ly-49 + (8%). After culture in 103 
U/ml IL-2 for  6  d,  the  cells were 
washed twice and assayed. All subsets 
were >195% pure for their respective 
markers  at the time of assay. Target 
cells were labeled for 1.5 h with slCr. 
NK cells were assayed against target 
cells at E/T ratios  of 20:1, 7:1, and 
2:1, and results were expressed as per- 
centage of cytotoxicity. This is a rep- 
resentative experiment of at least three 
similar assays performed. 
299  Mason  et al. Table  2.  mAb to LGL-I  and Ly-49 Overcome Class I Inhibition of NK Cells 
mAb  LGL- 1 +  Ly-49-  LGL-  1 +  Ly-49 +  LGL-1 - Ly-49-  LGL-  1 - Ly-49  + 
NK Cell Subsets vs P815 
Media  409  15  1,429  34 
Ry2A (control)  376  16  1,589  36 
4Dll  2,144  39  1,310  44 
Ly-2.2 (control)  239  13  892  32 
PK136  1,200  38  2,016  66 
A1  354  52  800  2,548 
4Dll  +  A1  2,144  1,931  1,193  3,123 
NK Cell Subsets vs  WEHI-164 
Media  1,675  82  2,513  61 
R72A  1,708  67  2,629  70 
4Dll  3,501  127  2,611  64 
Ly-2.2  1,032  55  2,456  62 
PK136  1,355  67  2,084  45 
A1  1,256  400  2,213  1,253 
4Dll  +  A1  3,788  2,283  2,263  1,139 
NK cells were enriched from B6 spleens, stained with 4Dll, PE, and A1 + FetMT2A, and sorted into the respective subsets: LGL-1  +Ly-49- (32%); 
LGL-l+Ly-49 + (11%); LGL-1-Ly-49- (47%); and LGL-1-Ly-49 + (9%).  After culture in 103 U/ml IL-2 for 6 d, the cells were washed twice 
and assayed. P815 and WEHI-164 were labeled with slCr. NK cells were assayed against P815 at E/T ratios starting at 10:1 and against WEHI-164 
at E/T ratios starting at 3:1. mAbs were added to the cytotoxicity assay at a final concentration of 2 #g/well and remained for the 4-h assay. Results 
are expressed at LU 30% per 107 cells. Ky2A is a negative isotype control mAb for 41911, and Ly-2.2 is a negative isotype control mAb for A1 
and PK136. These results are representative of at least three similar assays. 
toxicity by P815 targets was caused by the presence of class 
I  on their  surface,  we performed cytotoxicity assays  in the 
presence of various class I antibodies. Data presented in Fig. 
7 indicate that two class I proteins may be recognized by LGL-1 
and inhibit  cytotoxicity. Antibodies  to H2-L  a and  H2-D  a 
were very effective at  enhancing  cytotoxicity against  P815 
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Figure  7.  Antibodies to H2-L  d and H2-D  d enhance cytotoxicity of 
P815 targets by LGL-1  + cells. NK cells from B6 mice were enriched, sorted 
into LGL-1  +Ly-49- and Ly-49+LGL-1- subsets, and cultured for 6-10 d 
in IL-2. After washing twice, NK cells were tested against P815 targets 
at an E/T ratio of 10:1 in a 4-h slCr release assay. Various antibodies to 
either LGL-1, Ly-49,  or a variety of  class I proteins were included at a final 
concentration of 1-2 pg per well. Each group consisted of four replicates; 
the SEM are denoted by the error bars. This is one of two representative 
experiments performed. 
target cells.  LGL-1 +Ly-49- NK cells showed baseline cyto- 
toxic activity between 10 and 20%, depending on the partic- 
ular control antibody added. When antibodies to either H2- 
L d or H2-D  a were added, however, cytotoxicity increased to 
65-70%. It must be noted that only antibodies to the c~acx2 
domains  of H2-L  d and H2-D  d were effective at  enhancing 
the cytotoxic response of these ceils.  Antibodies to the H2- 
D a  (a3  domain)  and  the  H2-L  d  (or3 domain)  were  not 
capable  of enhancing  cytotoxicity  (data  not  shown).  Ly- 
49+LGL-1 -  cells  demonstrated  enhanced  cytotoxicity  of 
P815  targets  only  in  response  to  the  addition  of otH2- 
D'lotlcxz,  as demonstrated in previous studies  (7).  The data 
in Fig. 7 strongly implicate class I expression of H2-L  a and 
H2-D  d as inhibitory molecules that may bind to the LGL-1 
receptor on NK cells.  Similar experiments with Con A lym- 
phoblasts from B6 versus BALB/c mice demonstrated almost 
identical  results  to  those  seen  with  P815.  LGL-l+Ly-49  - 
NK cells were not able to kill BALB/c blasts alone, but upon 
addition of antibodies to H2-Daotlcz2 and H2-Laotlot2, cyto- 
toxicity was greatly augmented when compared with con- 
trol antibodies (data not shown). Data obtained using anti- 
bodies  to  both  the  effector  calls  (4Dll)  and  target  ceils 
(H2-Daotlo~2  and  H2-Ldotlot2)  provide  strong  evidence  for 
the  involvement  of H2-D a  and  H2-L  a  as  ligands  for  the 
LGL-1 receptor molecule.  Significant differences are there- 
fore observed in the binding of class I molecules by LGL-1 
and Ly-49. Ly-49 recognizes H2-Daottot2 and H2-D  k, where- 
as LGL-1 recognizes both H2-Lacr  and H2-Daalaz. 
300  Cloning LGL-I Discussion 
The cloning and sequencing of the murine LGL-1 cDNA 
has revealed it to be a member of the Ly-49 gene family, which 
belongs to the C-type lectin family of type II transmembrane 
proteins.  This  group  of proteins  includes  NKR-P1,  the 
asialoglycoprotein receptor, the low affinity receptors for IgE 
(FceRII) (25), and the CD69 early lymphocyte activation gene 
(26).  Another  NK-specific protein  on  murine  NK  cells, 
SW5E6,  has  recently been found  to  be  an  Ly-49  family 
member. The high degree of homology observed between 
the LGL-1  and Ly-49 proteins is most notable in that they 
share 10 of 11 extracellular cysteines.  This high percentage 
of cysteines accounts for the highly disulfide-linked nature 
of these proteins when analyzed on SDS-PAGE and further 
suggests similar functional characteristics. It also must be men- 
tioned that recent crosshybridization assays by Smith et al. 
(27) using Ly-49 cDNA has resulted in the detection of a 
number of Ly-49-related genes, including one that appears 
to be nearly identical to LGL-1. Therefore, using the nomen- 
clature of Yokoyama and coworkers, LGL-1 is Ly-49G2, 5E6 
is Ly-49C, and Ly-49 is Ly-49A. It must be noted, however, 
that LGL-1 is only 97% homologous to the Ly-49G2 cDNA 
isolated from B6 mice, and may therefore represent the C.B.17 
SCID form of Ly-49G2. 
Ly-49G2 and Ly-49A are restricted in their lymphoid dis- 
tribution, and are predominantly found to reside on subsets 
of murine NK cells. Since Ly-49 has been shown to function 
as an inhibitor of lysis when in contact with class I molecules 
(H-2D a, H-2Dk), we were interested in examining LGL-1 § 
cells for similar functional characteristics. Previous data from 
this laboratory indicated that the LGL-1 molecule was a poten- 
tial triggering molecule on NK cells, as it appeared to mediate 
RADCC (21).  Since mAb 4Dll was capable of enhancing 
lysis of P815 target cells (FeyRll +), we believed this to be 
mediated by a RADCC-type mechanism. However, mAb 
2.4G2 against the FcyRII was not able to block 4D11-induced 
lysis, but could block RADCC induced by mAb PK-136. 
These results suggested that alternative mechanisms may exist 
for the enhanced lysis of P815 target cells when using mAb 
4Dll. The results of our present studies indicate that the LGL-1 
molecule on NK cells, when bound to its appropriate ligand, 
may initiate an inhibitory signal in NK cells,  as seen with 
Ly-49. When we analyze either total LGL-1 § cells or LGL- 
1+Ly-49-  NK cells,  there appears  to be a selective  inhibi- 
tion of lysis that correlates with the degree of expression of 
H-2D a on target cells. This inhibition of lysis is not limited 
to tumor cell targets.  Normal Con A  lymphoblasts from 
BALB/c (H-2a), but not B6 (H-2b), mice are relatively resis- 
tant to lysis by LGL-1 + NK cells. We also have performed 
lytic assays with LGL-1 + and LGL-1- cells against BALB/c 
x  C57BL/6 F1 Con A lymphoblasts, in which lysis is greatly 
reduced in LGL-1 + subset  (data not shown). Addition of 
mAb 4Dll to assays in which LGL-1 + cells are tested against 
either  P815  (FcyRII +)  or  WEHI-164  (Fc'yRII-)  targets 
results in enhanced lysis of both targets when compared with 
control antibodies. This data suggests that the LGL-1 mole- 
cule, when blocked by the 4Dll antibody, is no longer able 
to  deliver  negative  signals  from  H-2  d+  target  cells.  The 
results of these studies suggest that the LGL-1 molecule may 
interact with class I H-2  a or a closely related molecule on 
the target cell membrane. 
In an attempt to further characterize the LGL-1 ligand, 
cytotoxicity assays were performed in which LGL-1 + cells 
were assayed against P815 and Con A blasts in the presence 
of various antibodies to class I molecules. Our data suggest 
that LGL-1 recognizes both H-2D a and H2-L  a as inhibitory 
molecules on target cells.  Of interest is the fact that only 
antibodies to the c~1o~2  peptide-binding region of these class 
I molecules are able to overcome their inhibitory effects. An- 
tibodies recognizing the c~3 domains of H2-D a or H2-L  a 
have little or no effect on cytotoxicity. These findings are 
important  in  two  respects.  First,  they establish  a  unique 
specificity  for LGL-1 + NK cells in recognizing H2-D a and 
H2-L  a. This specificity appears  to be distinct from that of 
Ly-49A, which recognizes H2-D a and H2-K  a. Second is the 
relative importance of the o~1o~2  domain of these class I mol- 
ecules. Since both Ly-49 and LGL-1  appear to be inhibited 
by the peptide-binding region of class I molecules, it empha- 
sizes the potential significance of the peptides presented in 
the binding domain of ctlt~2. This is particularly relevant to 
LGL-1 because of its limited inhibition by H-2Da-expressing 
tumor targets. The ability of class I molecules on target cells 
to inhibit cytotoxicity by LGL-1 + cells may be governed by 
the degree of class I expression, unique peptides presented 
by a particular cell type, or differential glycosylation of these 
class I molecules. 
Transfections of different class I molecules into class I- 
target cells also will help to further define the appropriate 
ligand for LGL-1.  Recent work by Kane (28)  has demon- 
strated that Ly-49 is capable of binding to H2-D a and H2-D k 
in a density-dependent manner. These results, along with the 
fact that there appear to be a number of Ly-49 family members 
(15, 29), suggest that these proteins may represent a group 
of molecules with different affinities  for class I. Studies by 
Yokoyama et al. (15) have demonstrated that there are at least 
five RFLP patterns in inbred mice that are displayed by Ly-49 
family members, and all appear to reside on chromosome 6. 
One question raised by these data is why more than one mol- 
ecule would be present on different NK cell subsets that might 
recognize the same class I molecule, albeit with different affini- 
ties.  It will also be interesting to wait for the development 
of mAbs to the other members of the Ly-49 family to see 
if they have similar functional attributes. Further studies also 
are necessary to determine why Ly-49 and possibly LGL-1 
are inhibited by class I molecules of allogeneic rather than 
syngeneic animals. Even if the fine specificity of binding is 
found to reside in the peptides that occupy the class I mole- 
cules (4, 8), it would be expected that if this protein-ligand 
interaction was to avoid lysis of "self" it would be present 
in a syngeneic environment. Only further characterization 
of the members of the Ly-49 gene family and the develop- 
ment of mAbs to their respective proteins will help to define 
their true physiological roles. 
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